Acknowledgements
Cancer
ONCOLOGY, THORACIC, CANCER
The authors would like to thank the patients, their families, and all CTONG1804 Trial investigators for their participation. This work was supported by the Bristol Myers Squibb (grant number BMSCA209-8D8) and the Chinese Thoracic Oncology Group (CTONG1804). ctDNA analysis was performed by Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis and the Berry Oncology Corporation without compensation.